Pfizer reportedly aims to market OTC Lipitor after patent expires

Pfizer is considering launching a nonprescription form of blockbuster cholesterol-lowering drug Lipitor after a key patent expires in November, sources said. However, Pfizer is expected to have trouble doing so because of the FDA's concern that patients will misuse statins without medical guidance.

View Full Article in:

New York Times (tiered subscription model), The · Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Statistician I (US/TB/00/0028/SL)
Abbott
Santa Clara, CA
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA